ArticleJCI insight2023

Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell- and CXCR3-dependent manner.

Michael Brandon Ware et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.